167 related articles for article (PubMed ID: 16251126)
1. Platelet-activating factor in human normal tears.
Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
[TBL] [Abstract][Full Text] [Related]
3. Renal allograft platelet activating factor synthesis during acute cellular rejection.
Mangino MJ; Anderson CB; Murphy MK; Turk J
J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
[TBL] [Abstract][Full Text] [Related]
4. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
Kato M; Mano H; Ota A; Konomi K; Nakata K
J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
[TBL] [Abstract][Full Text] [Related]
5. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines in normal human tears.
Nakamura Y; Sotozono C; Kinoshita S
Curr Eye Res; 1998 Jun; 17(6):673-6. PubMed ID: 9663859
[TBL] [Abstract][Full Text] [Related]
7. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine).
Harrison KA; Clay KL; Murphy RC
J Mass Spectrom; 1999 Apr; 34(4):330-5. PubMed ID: 10226361
[TBL] [Abstract][Full Text] [Related]
8. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
9. Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
Masugi F; Sakaguchi K; Saeki S; Imaoka M; Ogihara T
J Lipid Mediat; 1989; 1(6):341-8. PubMed ID: 2519902
[TBL] [Abstract][Full Text] [Related]
10. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
Ramesha CS; Pickett WC
J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
[TBL] [Abstract][Full Text] [Related]
11. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
Christman BW; Gay JC; Christman JW; Prakash C; Blair IA
Biol Mass Spectrom; 1991 Sep; 20(9):545-52. PubMed ID: 1782204
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of major platelet activating factors from human plasma.
Kim SJ; Back SH; Koh JM; Yoo HJ
Anal Bioanal Chem; 2014 May; 406(13):3111-8. PubMed ID: 24682147
[TBL] [Abstract][Full Text] [Related]
13. [Platelet-activating factor in Japanese cedar pollinosis].
Nakamura T; Ishihara K; Kuriyama M; Miyamoto T; Matsumura Y
Arerugi; 1990 Jun; 39(6):553-6. PubMed ID: 2222198
[TBL] [Abstract][Full Text] [Related]
14. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
Whitehead SN; Hou W; Ethier M; Smith JC; Bourgeois A; Denis R; Bennett SA; Figeys D
Anal Chem; 2007 Nov; 79(22):8539-48. PubMed ID: 17949058
[TBL] [Abstract][Full Text] [Related]
15. Potential angiogenic role of platelet-activating factor in human breast cancer.
Montrucchio G; Sapino A; Bussolati B; Ghisolfi G; Rizea-Savu S; Silvestro L; Lupia E; Camussi G
Am J Pathol; 1998 Nov; 153(5):1589-96. PubMed ID: 9811351
[TBL] [Abstract][Full Text] [Related]
16. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
[TBL] [Abstract][Full Text] [Related]
17. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics.
Detopoulou P; Nomikos T; Fragopoulou E; Stamatakis G; Panagiotakos DB; Antonopoulou S
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):43-9. PubMed ID: 22079887
[TBL] [Abstract][Full Text] [Related]
18. L-carnitine and short chain ester in tears from patients with dry eye.
Pescosolido N; Imperatrice B; Koverech A; Messano M
Optom Vis Sci; 2009 Feb; 86(2):E132-8. PubMed ID: 19156017
[TBL] [Abstract][Full Text] [Related]
19. Structural heterogeneity of platelet-activating factor produced by murine preimplantation embryos.
Ammit AJ; Wells XE; O'Neill C
Hum Reprod; 1992 Jul; 7(6):865-70. PubMed ID: 1500487
[TBL] [Abstract][Full Text] [Related]
20. Binding of platelet-activating factor to oviductal membranes during early pregnancy in the rabbit.
Yang YQ; Kudolo GB; Harper MJ
J Lipid Mediat; 1992 Feb; 5(1):77-96. PubMed ID: 1391740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
